6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone

C154H138BrN43O12 — CID 162049974

About 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone

6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone (PubChem CID 162049974) has the molecular formula C154H138BrN43O12 and a molecular weight of 2862.99 g/mol. Its IUPAC name is 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone.

Molecular Properties

• Compound Name: 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone
• PubChem CID: 162049974
• Molecular Formula: C154H138BrN43O12
• Molecular Weight: 2862.99 g/mol
• Exact Mass: 2860.07
• IUPAC Name: 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone
• SMILES: Cc1cc(Nc2ncnc3ccc(Br)cc23)ccc1Oc1cc2nncn2cn1.Cc1cc(Nc2ncnc3ccc(CC(=O)N4CCOCC4)cc23)ccc1Oc1cc2nncn2cn1.Cc1cc(Nc2ncnc3ccc(CC4=NC(C)(C)CO4)cc23)ccc1Oc1cc2nccn2cn1.Cc1cc(Nc2ncnc3ccc(CC4=NC(C)(C)CO4)cc23)ccc1Oc1cc2nccn2cn1.Cc1cc(Nc2ncnc3ccc(CC4=NC(C)(C)CO4)cc23)ccc1Oc1cc2nncn2cn1.Cc1cc(Nc2ncnc3ccc(CC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ccnc2c1
• InChI: InChI=1S/C28H26N6O2.2C27H25N7O2.C26H24N8O3.C26H24N8O2.C20H14BrN7O/c1-18-12-20(5-7-24(18)36-21-8-10-34-11-9-29-25(34)15-21)32-27-22-13-19(4-6-23(22)30-17-31-27)14-26-33-28(2,3)16-35-26;2*1-17-10-19(5-7-22(17)36-24-13-23-28-8-9-34(23)16-31-24)32-26-20-11-18(4-6-21(20)29-15-30-26)12-25-33-27(2,3)14-35-25;1-17-10-19(3-5-22(17)37-24-13-23-32-30-16-34(23)15-29-24)31-26-20-11-18(2-4-21(20)27-14-28-26)12-25(35)33-6-8-36-9-7-33;1-16-8-18(5-7-21(16)36-23-11-22-33-30-15-34(22)14-29-23)31-25-19-9-17(4-6-20(19)27-13-28-25)10-24-32-26(2,3)12-35-24;1-12-6-14(26-20-15-7-13(21)2-4-16(15)22-9-23-20)3-5-17(12)29-19-8-18-27-25-11-28(18)10-24-19/h4-13,15,17H,14,16H2,1-3H3,(H,30,31,32);2*4-11,13,15-16H,12,14H2,1-3H3,(H,29,30,32);2-5,10-11,13-16H,6-9,12H2,1H3,(H,27,28,31);4-9,11,13-15H,10,12H2,1-3H3,(H,27,28,31);2-11H,1H3,(H,22,23,26)
• InChIKey: YYKNPGFVGKNMKA-UHFFFAOYSA-N
• XLogP: 29.05
• TPSA: 605.06 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 54
• Rotatable Bonds: 34
• Heavy Atoms: 210
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2862.99
LogP ≤ 5	29.05
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	54

Frequently Asked Questions

What is the IUPAC name of 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone?

The IUPAC name of 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone (CID 162049974) is 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone.

What is the SMILES notation for 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone?

The canonical SMILES for 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone is Cc1cc(Nc2ncnc3ccc(Br)cc23)ccc1Oc1cc2nncn2cn1.Cc1cc(Nc2ncnc3ccc(CC(=O)N4CCOCC4)cc23)ccc1Oc1cc2nncn2cn1.Cc1cc(Nc2ncnc3ccc(CC4=NC(C)(C)CO4)cc23)ccc1Oc1cc2nccn2cn1.Cc1cc(Nc2ncnc3ccc(CC4=NC(C)(C)CO4)cc23)ccc1Oc1cc2nccn2cn1.Cc1cc(Nc2ncnc3ccc(CC4=NC(C)(C)CO4)cc23)ccc1Oc1cc2nncn2cn1.Cc1cc(Nc2ncnc3ccc(CC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ccnc2c1.

What is the InChIKey of 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone?

The InChIKey is YYKNPGFVGKNMKA-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26N6O2.2C27H25N7O2.C26H24N8O3.C26H24N8O2.C20H14BrN7O/c1-18-12-20(5-7-24(18)36-21-8-10-34-11-9-29-25(34)15-21)32-27-22-13-19(4-6-23(22)30-17-31-27)14-26-33-28(2,3)16-35-26;2*1-17-10-19(5-7-22(17)36-24-13-23-28-8-9-34(23)16-31-24)32-26-20-11-18(4-6-21(20)29-15-30-26)12-25-33-27(2,3)14-35-25;1-17-10-19(3-5-22(17)37-24-13-23-32-30-16-34(23)15-29-24)31-26-20-11-18(2-4-21(20)27-14-28-26)12-25(35)33-6-8-36-9-7-33;1-16-8-18(5-7-21(16)36-23-11-22-33-30-15-34(22)14-29-23)31-25-19-9-17(4-6-20(19)27-13-28-25)10-24-32-26(2,3)12-35-24;1-12-6-14(26-20-15-7-13(21)2-4-16(15)22-9-23-20)3-5-17(12)29-19-8-18-27-25-11-28(18)10-24-19/h4-13,15,17H,14,16H2,1-3H3,(H,30,31,32);2*4-11,13,15-16H,12,14H2,1-3H3,(H,29,30,32);2-5,10-11,13-16H,6-9,12H2,1H3,(H,27,28,31);4-9,11,13-15H,10,12H2,1-3H3,(H,27,28,31);2-11H,1H3,(H,22,23,26).

What are the key properties of 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone?

6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone has a molecular weight of 2862.99 g/mol, XLogP of 29.05, 34 rotatable bonds, 6 hydrogen bond donors, and 54 hydrogen bond acceptors.

Where does this data come from?

All data for 6-bromo-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine;bis(6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylphenyl)quinazolin-4-amine);6-[(4,4-dimethyl-5H-1,3-oxazol-2-yl)methyl]-N-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;2-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-1-morpholin-4-ylethanone is sourced from PubChem (CID 162049974), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).